Serum Institute gets nod to export vaccines to COVAX


The Pune based vaccines manufacturer Serum Institute of India (SII) has got the nod to export Covid vaccines under the COVAX programme, said a source on Monday.

The ministry has allowed SII to export 50 lakh doses of COVID-19 vaccine Covishield to the COVAX, an UN Global body.

COVAX is co-led by Gavi, the Coalition for Epidemic Preparedness Innovations (CEPI) and the World Health Organization that aims to accelerate the development and manufacture of Covid vaccines.

Union Health Minister Mansukh Mandaviya had announced that India will be resuming export of vaccines under Vaccine Maitri in the fourth quarter starting from October. He had said that vaccine export will resume to fulfill the commitment of India towards COVAX in line with the motto ‘Vasudhaiva Kutumbakam’.

India stopped the Covid-19 vaccines in April this year after a severe surge in Covid case during the second wave to jab its own population. However, prior to the export ban, India had either sold or donated 66 million doses to nearly 100 countries. While announcing to resume the vaccine exports under Vaccine Maitri program, the Health Minister said that the surplus supply of vaccines will be used to fulfill the commitment towards the world for the collective fight against Covid-19.

(Source: EconomicTimesOfIndia, 2021)


GAVI and Indian biologics companies will present on logistics at the Biologistics World Asia 2022, March 29-31, in Singapore.


Leave A Comment

Leave a Reply

Your email address will not be published.